VAERS reports by lot

GSK Varicella/Shingles lot 2BR9G: VAERS reports

32 VAERS reports list lot 2BR9G as a GSK Varicella/Shingles vaccine, received between 2023-04-11 and 2024-08-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
6%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1719%
General / Systemic (non-local)1517%
Cardiac / Cardiovascular1213%
Gastrointestinal1213%
Dermatological (non-injection-site)1112%
Neurological78%
Musculoskeletal78%
Allergic / Anaphylactic56%
Thrombotic / Hematological22%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Colorado3
Florida3
South Carolina2
North Carolina2
Arkansas2
Missouri2
Arizona2
California2
Georgia2
Idaho1
New York1
Pennsylvania1

Reports by month received

2023-043
2023-0511
2023-066
2023-075
2023-081
2023-102
2023-121
2024-051
2024-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.